Brimonidine 0.1% 0.1%

Brimonidine tartrate ophthalmic solution 0.1% is an alpha-2 adrenergic agonist indicated to reduce elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. This is a lower-strength formulation than the catalog's existing 0.2% Brimonidine Tartrate item. The typical dose is one drop in the affected eye three times daily, approximately 8 hours apart. Common side effects include eye irritation, allergic conjunctivitis, and dry mouth.